NSE filing, NSE: RELIANCE. Summary written from the filing by ALFA Finder's alert engine.
Reliance Industries Ltd: key numbers
- Share price
- ₹1,158.00
- Market cap
- ₹15,67,068 Cr
- Revenue (annual)
- ₹10,57,035 Cr
- Net profit (annual)
- ₹80,775 Cr
- P/E (TTM)
- 21.0×Sector 17.8×
- Promoter holding
- 50.44%-0.04% QoQ
- FII holding
- 16.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Reliance Industries Ltd
All →Reliance Industries Board Meeting Date
Reliance Industries will hold a board meeting on October 30, 2026 to consider quarterly results and NCD fundraising. This advance notice reports no decisions yet.
Reliance Industries IPO
Jio Platforms fixed its IPO issue price at Rs.1,119 per share and filed the prospectus. The offer of up to 27 crore shares closed on October 23.
- Value
- ₹30,213 Cr
Reliance Industries Credit Rating
Reliance Industries Limited received reaffirmed credit ratings from ICRA for its non-convertible debentures and commercial paper, and a new rating for its bank loan facilities.
Reliance Industries Other Announcement
Reliance Industries filed its quarterly shareholding pattern for the period ended September 30, 2026, as mandated by SEBI regulations. No material changes occurred in promoter shareholding.
Reliance Industries Debt & Borrowing: ₹218 Cr
Reliance Industries paid ₹218 Crore annual interest on its PPD Series G NCDs on the due date of 19 October 2026, confirming timely debt servicing.
- Value
- ₹218.0 Cr
Reliance Industries IPO
Reliance Industries filed the Red Herring Prospectus for its subsidiary Jio Platforms Limited's upcoming IPO. The IPO is scheduled to open on October 21, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date